Keynote Speakers

5th International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (NDDTE’20)

The keynote speakers for the 5th International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering (NDDTE'20) will be announced shortly! Thank you for your patience.

Dr. Josef Jampilek

Dr. Josef Jampilek
Comenius University, Slovakia
Keynote Speaker

Josef Jampilek completed his Ph.D. degree in Medicinal Chemistry at the Faculty of Pharmacy of the Charles University (Czech Republic) in 2004. In 2004-2011, he worked in expert and managerial posts in the R&D Division of the pharmaceutical company Zentiva (Czech Republic). Prof. Jampilek deepened his professional knowledge at the Medicinal Chemistry Institute of the Heidelberg University (Germany) and at multiple specialized courses. In 2017, he was designated as a Full Professor of Medicinal Chemistry. At present he works at the Regional Centre of Advanced Technologies and Materials, Palacky University in Olomouc (Czech Republic) and the Faculty of Natural Sciences, Comenius University in Bratislava (Slovakia). In addition, he is a visiting professor at the University of Silesia in Katowice (Poland) and Hong Kong Baptist University (Hong Kong SAR, China) and an invited professor/expert at various higher educational institutions. He is an author/co-author of more than 30 patents/patent applications, more than 200 peer-reviewed scientific publications, 7 university textbooks, more than 30 chapters in monographs, and many invited lectures at international conferences and workshops. He also received several awards for his scientific results, e.g., from Aventis, Elsevier, Willey, Sanofi and FDA. The research interests of Prof. Jampilek include design, synthesis, and structure-activity relationships of heterocyclic compounds as anti-invasive and anti-inflammatory agents as well as nanosystems. He is also interested in ADME, drug bioavailability and solid-state pharmaceutical analysis.

Topic of Keynote: Impact of Nanoparticles on Pathogenic Fungi
Keynote Abstract

Dr. Maria Josè Alonso

Dr. Maria José Alonso
Universidade de Santiago de Compostela, Spain
Keynote Speaker

María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Nanotechnology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. She is the author of 290 scientific contributions with more than 29,400 cites (H factor 90) and the inventor of 22 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010). Recently, she become part of the “Power List” of the most influential researchers in the field of Biopharmaceuticals (The Medicine Maker, 2020)

She has served to the Release Society (CRS) for 15 years and she is currently Past President of the Controlled Release Society (CRS). She is also Editor-in-Chief of the Drug Delivery and Translational Research, an official journal of the CRS, and she is part of the editorial board of 11 journals.

She has received 33 awards, among them the ”Research and Education Excellence Medal” granted by the Spanish Government, the “Jaime I Award”, the General Council of Pharmacy Medal, and other awards granted by scientific organizations, such as the ”Marie Junot Award” of the APGI, the “Founders Award”, the “Outstanding Service Award” and the “Women in Sciences Award” of the CRS. She was also recently awarded by the AIM-HI Women’s Venture Competition program born out of the National Foundation for Cancer Research (NFCR).

She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a Fellow of the Controlled Release Society, a member of the Royal Academy of Pharmacy of Spain, the Royal Academy of Sciences of Galicia, the Royal Academy of Pharmacy in Galicia and a member of the US National Academy of Medicine (NAM).

She was the Vice-rector of Research and Innovation of the USC (2006-10).

Topic of Keynote: Nanotechnology as a Tool to help Macromolecules Overcoming Biological Barriers
Keynote Abstract